Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
ID
Žnidaršič, Neža
(
Author
),
ID
Štrbenc, Malan
(
Author
),
ID
Grgurevič, Neža
(
Author
),
ID
Snoj, Tomaž
(
Author
)
PDF - Presentation file,
Download
(882,63 KB)
MD5: 858AD2DFAEB7443BC36F46AC8CEBE7A9
URL - Source URL, Visit
https://www.frontiersin.org/articles/10.3389/fvets.2023.1125618/full
Image galllery
Abstract
The cholinergic system is involved in the regulation of all organ systems and has acetylcholine (ACh) as almost its only neurotransmitter. Any substance is called cholinergic if it can alter the action of acetylcholine. Cholinesterases (ChEs) are enzymes that enable the hydrolysis of acetylcholine and in this way ensure homeostasis in cholinergic synapses. Cholinesterase inhibitors (ChEi) are a group of indirect-acting cholinergic agonists that influence the activity of the cholinergic system. Several compounds that can inhibit cholinesterases are of importance to veterinary medicine from pharmacological and toxicological perspective. The frequency of their use in veterinary medicine has fluctuated over the years and is now reduced to a minimum. They are mainly used in agriculture as pesticides, and some are rarely used as parasiticides for companion animals and livestock. In recent years, interest in the use of new cholinesterase inhibitors has increased since canine cognitive dysfunction (CCD) became a recognized and extensively studied disease. Similar to Alzheimer’s disease (AD) in humans, CCD can be treated with cholinesterase inhibitors that cross the blood–brain barrier. In this review, the mammalian cholinergic system and the drugs that interact with cholinesterases are introduced. Cholinesterase inhibitors that can be used for the treatment of CCD are described in detail.
Language:
English
Keywords:
cholinergic system
,
cholinesterase inhibitors
,
organophosphates
,
carbamates
,
canine cognitive dysfunction
,
cognitive dysfunction
,
dogs
Work type:
Article
Typology:
1.02 - Review Article
Organization:
VF - Veterinary Faculty
Publication status:
Published
Publication version:
Version of Record
Year:
2023
Number of pages:
11 str.
Numbering:
Vol. 10, art. 1125618
PID:
20.500.12556/RUL-144645
UDC:
636.09:577:612
ISSN on article:
2297-1769
DOI:
10.3389/fvets.2023.1125618
COBISS.SI-ID:
144140035
Publication date in RUL:
06.03.2023
Views:
744
Downloads:
95
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Frontiers in veterinary science
Shortened title:
Front. vet. sci.
Publisher:
Frontiers Media
ISSN:
2297-1769
COBISS.SI-ID:
3969402
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P4-0053
Name:
Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back